Skip to main content

Diabetic Nephropathy clinical trials at UCSF
1 in progress, 1 open to new patients

  • Study Of Diabetic Nephropathy With Atrasentan

    open to eligible people ages 18–85

    This study is being conducted to evaluate the effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.

    San Francisco, California and other locations